task_ Montse Ferrando

Hello people I want to talk to you about... COVID-19 vaccine The one developed by University of Oxford together with AstraZeneca Recently they published the results... so the overall efficacy of the vaccine And the number was 70% Now, compare to the other two with numbers in the midst of 90-95% This look bad However, it turns down that made a mistake With about 300 people volunteers Because they gave to these people allow a those regimens of the vaccine So basically, they gave the same amount of liquid But there was less amount of vaccine in the liquid, it was diluted So... this was a mistake But it turns up That when you do that in the first dose And then you give the full of mound of the second It looks like: the overall efficacy rises from 70% to a 90% Now, taking into account That this vaccine is cheaper than the other two It is in the rate of 2-3 euros rather than 20 whatever And that it can be stored in fridges, at fridge temperature Around eight degrees positive rather than minus twenty or minus eighty So, of course that all this two characteristics make this vaccine much better So the only problem would be the lower efficacy But, if it turns out... And the overall efficacy is actually in the midst of 90% Then that's really good So it's look like they are going to make new trails now But then of course some people are saying nah... If they are making new ones is because... they didn't do right the first time and so one... So it's tricky